ESMA has updated its manual on transparency: new guidance on identifying OTC derivatives subject to transparency requirements, on how their identifying reference data should be provided (including for the consolidated tape), and on the tick-size regime, with the published Q&As folded in.

What it means for you

A follow-up to the 1 September reference-data change: check your OTC instrument classification and the reference data you publish against the new guidance.